Autonomic Disorders Certification Examination Committee Contributors
Elisabeth Golden, MD, Chair, UT Southwestern
Disclosures: Received honoraria from The Dysautonomia Project for serving on the faculty of The Residents Course and for keynote speaker at DysCourse (patient education program). Had non-compensated relationship as Medical Advisor to The Dysautonomia Project (nonprofit educational organization).
Melissa M. Cortez, DO, Vice Chair, University of Utah Health
Disclosures: Received compensation from NIH RECOVER - DSMB Member. Received compensation from NIH Ad Hoc - Study Section – Reviewer.
Satish Raj, MD, Vice Chair, University of Calgary
Disclosures: Received compensation for serving as a consultant for Regeneron, argenx, Antag Pharma, and Lumia Health. Received compensation for serving on a scientific advisory board for Novo Nordisk, 1 scientific advisory board meeting (no ongoing relationship). Received compensation for serving as Associate Editor, Autonomic Neurosciences. Received compensation for serving as an expert witness advising on whether someone has POTS and possible mechanisms of injury. Received research support from Dysautonomia International, from Standing Up to POTS, from Heart & Stroke Foundation of Canada, from Canerector Foundation, from Medtronic - research enrollment, from Theravance - research enrolment, and from Regeneron - research enrolment – all research-related funds given to Dr. Raj’s institution.
Srikanth Muppidi, MD, Stanford Neuroscience Health Center
Disclosures: Received compensation from advisory board meetings for Alexion, argenx, UCB, J&J, Kyverna, and Arcellex.
Nathaniel Robbins, MD, Mass General / Brigham
Disclosures: Received compensation from Theravance Biopharma - expert consultant/scientific advisory. Received research support from NIH and Theravance. Received research support from DOJ and DHHS: legal expert. Received honoraria from the Dysautonomia project.
Howard Snapper, MD, WellStar Medical Group
Disclosures: Nothing to disclose.
Kamal Shouman, MD, Mayo Clinic – Rochester
Disclosures: Nothing to disclose.
Meredith Bryarly, MD, UT Southwestern Medical Center
Disclosures: Spouse has traded and owned common stock (including serapta, altimmune, CGTX, IMRX). Currently only owns stock in CGTX. Dr. Bryarly received research support from Theravance pharmaceuticals and an NIH grant.
Gisela G. Chelimsky, MD, Virginia Commonwealth University
Disclosures: Self and spouse have received compensation work as expert witness in legal cases. Received research support from several NIH and AHRQ grants. Spouse received compensation as grant reviewer for NIH. Self and spouse both are co-owners of a company that teaches how to manage chronic pain in the biobehavioral approach (PainStakers, LLC). Participates on the examination committee of the American Board of Pediatrics gastroenterology sub-committee.
Ezequiel A. Piccione, MD, University of Nebraska Medical Center
Disclosures: Nothing to disclose.